ヒトの卵子凍結保存市場レポート：2031年までの動向、予測、競合分析

世界のヒトの卵子凍結保存市場の将来は、25～30歳女性、30～35歳女性、35～40歳女性市場に機会があり、有望視されています。世界のヒトの卵子凍結保存市場は、2025年から2031年にかけてCAGR 15％で成長すると予想されます。この市場の主な促進要因は、妊孕性温存の需要の高まり、凍結保存技術の成功率の上昇、生殖補助医療技術の採用の増加です。

• Lucintel社の予測では、タイプ別では急速凍結法が予測期間中に高い成長を遂げる見込みです。
• 用途別では、30～35歳女性が最も高い成長が見込まれています。
• 地域別では、北米が予測期間中に最も高い成長が見込まれています。

ヒトの卵子凍結保存市場の新たな動向

ヒトの卵子凍結保存市場は、技術と採用の両方に影響を与えるいくつかの新たな動向によって再定義されつつあります。これらの動向は、社会規範の変化、生殖技術の進歩、ヘルスケア政策の変化を捉えています。この市場の成長と進化を形作る5つの主要動向を以下に示します。

• 凍結保存法の強化：凍結保存法、特にガラス化法の進歩により、卵子凍結保存の成功率が大幅に向上しました。ガラス化により凍結中の氷結晶形成がなくなり、卵子の構造的完全性が保護され、生存率が向上しました。この方法によって卵子凍結はより信頼できるものとなり、広く普及するようになりました。技術の進歩に伴い、凍結保存法の進歩は保存できる卵子の質と量を増やし、市場をさらに成長させるに違いないです。
• 意識の高まりと社会的受容：社会的規範の変化に伴い、より多くの女性がキャリアや個人的なニーズのために妊孕性温存を選ぶようになってきています。卵子凍結保存とその利点に関する意識の高まりが、特に妊娠の延期を望む30～40歳の女性の間で、この需要を後押ししています。メディアへの露出や積極的な活動は、卵子凍結を生殖福祉の普通の側面として正常化するのに役立っています。生殖補助技術に対する社会的受容の高まりは、世界中で卵子凍結サービスの需要を高めると思われます。
• 妊孕性温存の保険適用：特定の地域では、妊孕性温存サービスが保険会社によってカバーされるようになってきており、卵子凍結保存をより経済的に実行可能なものにしています。この動向は米国で最もよく観察され、保険適用が不妊治療給付金の一部として卵子凍結をカバーし始めています。保険が適用されるようになると、より多くの女性が卵子凍結保存を利用する経済的な力を得ることになります。
• 人工知能との技術融合：ヒトの卵子凍結保存法における人工知能（AI）の統合は新しい動向です。AIは、凍結のための卵子選択を最大化し、卵子の質を評価し、胚培養法を強化するために活用されています。AIツールは、患者や不妊治療の専門家の意思決定機能を強化しながら、大規模なデータベースを調査し、卵子凍結の成功率を決定する能力を持っています。AIが不妊治療をより正確で効率的なものにし続けるにつれて、卵子凍結保存市場を大きく前進させるに違いないです。
• 政策支援と規制の進化：政策立案者は不妊治療に関するガイドラインをより多く提供しており、その結果、市場の標準化と安全性が向上しています。ほとんどの国では、卵子凍結保存の普及を確実にするために政策環境の変化が起きています。政府もまた、特に出生率の低下に対応するためのイニシアチブの一環として、妊孕性温存に対する政策的インセンティブを提供し始めています。このような政策の進展は、不妊治療クリニックが卵子凍結保存サービスを実施し、患者の成功と安全を確保するための明確な道筋を提供するものです。

ヒトの卵子凍結保存市場は、凍結保存技術の向上、社会の変化、規制当局の支援強化などの影響を受け、革命的な変化を遂げつつあります。技術の開発、社会的受容の拡大、保険適用範囲の拡大、AIの統合、政策の変化などの動向は、不妊治療の展望に革命をもたらしています。このような動向は市場の成長を促進するだけでなく、卵子凍結保存サービスの利用しやすさ、手頃な価格、全体的な成功率を向上させています。

ヒトの卵子凍結保存市場における最近の動向

ヒトの卵子凍結保存市場の最近の動向は、主に技術革新、社会規範の変化、規制環境の変化による影響を受けています。これらにより、世界中で妊孕性温存法の適用が増加しています。次のセクションでは、市場の現状を定義している5つの主要動向を明らかにします。

• ガラス固化技術の開発：ガラス固化による凍結保存は過去10年間の技術であり、ヒト卵子の凍結保存業界を一変させました。この技術は、凍結中の氷結晶の損傷から細胞を保護し、保存卵の品質と解凍時の成功率を向上させる。この技術により、卵子凍結はより効率的で信頼性の高いものとなり、妊孕性の保存を選択する女性にとってより良い結果をもたらすようになりました。
• 不妊治療サービスの増加：不妊治療センターは需要の増加に直面し、卵子凍結保存サービスをより頻繁に提供するようになりました。センターは現在、キャリアや個人的な要因で出産を遅らせたい女性のための卵子凍結パッケージまでサービスを広げています。その上、不妊治療サービスはますます低価格で利用しやすくなっており、より多くの人々が卵子凍結の恩恵を受けられるようになっています。この成長は、特に女性が不妊治療クリニックやサービスにアクセスできる都市部での市場拡大に拍車をかけています。
• 妊孕性温存に対する政府の政策支援：各国の政府は、出生率の低下に対処するための国家政策の一環として、妊孕性温存を支援し始めています。例えば、日本や欧州の一部の国々では、財政支援や医療費負担の軽減を通じた支援を提供することで、卵子凍結に踏み切る女性を説得しています。このような支援は、卵子凍結を生殖医療として正常化するプロセスを助け、卵子凍結の拡大と利用可能性を促しています。政府の政策変更に伴い、卵子凍結保存市場も継続的な成長が見込まれています。
• 医療目的での卵子凍結の重視：卵子凍結保存は現在、がん治療を受けている女性や生殖系に影響を及ぼす可能性のある他の病状の女性の妊孕性を維持するのに役立つなど、医療目的で行われることが多くなっています。医療目的での卵子凍結の可能性が知られるにつれ、子供を持つ能力を損なう可能性のある治療を受ける前に、生殖能力を維持するために卵子凍結保存を利用する女性が増えています。このような卵子凍結のヘルスケア利用は、選択的妊孕性温存の枠を超えて市場を広げ、凍結保存サービスの需要を高めています。
• 卵子の品質分析のためのAIとの技術の統合：凍結用卵子の品質評価にAIを応用することは、市場の新しい動向です。AI技術は卵子の質を評価し、受精に成功する確率を推定するために不妊治療クリニックに取り入れられています。この統合により、最高品質の卵子が確実に保存されることで、凍結保存がより効率的で成功しやすくなります。AIを搭載したツールは不妊治療プロセスの不可欠な一部となりつつあり、卵子凍結保存業界の技術革新に拍車をかけています。

ガラス固化技術の革新、サービスの選択肢の増加、政府の政策支持、医療用卵子凍結の成長、AIの導入など、ヒトの卵子凍結保存市場の新たな開発が市場に革命をもたらしています。これらの変化は市場の拡大を刺激し、アクセス性を高め、不妊治療の成功率を向上させ、最終的には女性に自分の生殖生活をよりコントロールできるようにし、卵子凍結保存が一般に受け入れられる道を開いています。

目次

第1章 エグゼクティブサマリー

第2章 世界のヒトの卵子凍結保存市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019～2024年）と予測（2025～2031年）
• 世界のヒトの卵子凍結保存市場の動向（2019～2024年）と予測（2025～2031年）
• タイプ別
  • 徐冷法
  • 急速冷凍プロセス
• 用途別
  • 25～30歳の女性
  • 30～35歳の女性
  • 35～40歳の女性
  • その他

第4章 2019年から2031年までの地域別市場動向と予測分析

• 地域別のヒトの卵子凍結保存市場
• 北米のヒトの卵子凍結保存市場
• 欧州のヒトの卵子凍結保存市場
• アジア太平洋地域のヒトの卵子凍結保存市場
• その他地域のヒトの卵子凍結保存市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別
  • 用途別
  • 地域別
• 世界のヒトの卵子凍結保存市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界のヒトの卵子凍結保存市場の能力拡大
  • 世界のヒトの卵子凍結保存市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Anova Fertility
• CCRM IVF
• Chill
• CREATE Fertility
• Extend Fertility
• HRC Fertility
• IVF Australia
• Kindbody
• London Women's Clinic
• Manchester Fertility

The future of the global human oocyte cryopreservation market looks promising with opportunities in the 25-30 year old female, 30-35 year old female, and 35-40 year old female markets. The global human oocyte cryopreservation market is expected to grow with a CAGR of 15% from 2025 to 2031. The major drivers for this market are the rising demand for fertility preservation, the growing success rates of cryopreservation techniques, and the increasing adoption of assisted reproductive technologies.

• Lucintel forecasts that, within the type category, flash-freezing process is expected to witness higher growth over the forecast period.
• Within the application category, 30-35 year old female is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market is being redefined by some emerging trends that affect both technology and adoption. These trends capture changing societal norms, advances in reproductive technologies, and changing healthcare policies. Five major trends shaping the growth and evolution of this market are listed below.

• Enhanced Cryopreservation Methods: Advances in cryopreservation methods, particularly vitrification, have significantly enhanced the success rates of oocyte cryopreservation. Vitrification does away with ice crystal formation during freezing, safeguarding the structural integrity of eggs and enhancing survival rates. This method has made egg freezing more dependable and widespread, leading to its uptake. With advancing technology, advances in cryopreservation methods are bound to increase the quality and quantity of eggs that can be preserved, growing the market even further.
• Growing Awareness and Social Acceptance: With changing social norms, more and more women are opting for fertility preservation for career or individual needs. Growing awareness about oocyte cryopreservation and its advantages is driving this demand, specifically among women aged between 30 and 40 who would like to defer pregnancy. Media exposure and activism have helped normalize egg freezing as an ordinary aspect of reproductive well-being. Increased social acceptance of assisted reproductive technologies is likely to enhance the demand for egg freezing services across the world.
• Insurance Coverage for Fertility Preservation: Fertility preservation services in certain regions are becoming increasingly covered by insurance companies, which is making oocyte cryopreservation more economically viable. The trend is best observed in the United States, where insurance coverage is starting to cover egg freezing as part of fertility preservation benefits. As insurance coverage increases, a greater number of women will be financially empowered to avail themselves of oocyte cryopreservation, hence increasing market growth and making these services more accessible to a broader population.
• Technology Convergence with Artificial Intelligence: Artificial intelligence (AI) integration in the human oocyte cryopreservation procedure is a new trend. AI is being utilized to maximize egg selection for freezing, evaluate oocyte quality, and enhance embryo culture methods. AI tools have the ability to examine large databases and determine the success rates of egg freezing while enhancing the decision-making function for patients and fertility experts. As AI keeps making fertility treatment more accurate and efficient, it is bound to drive the oocyte cryopreservation market forward in a major way.
• Policy Support and Evolution of Regulation: Policy makers are providing more guidelines regarding fertility preservation, which results in increased standardization and safety for the market. In most countries, the policy environment is undergoing changes to ensure the increased popularity of oocyte cryopreservation. Governments are also starting to provide policy incentives for fertility preservation, particularly as part of initiatives to meet declining birth rates. These policy developments offer clearer channels for fertility clinics to proceed and provide oocyte cryopreservation services and ensure patient success and safety.

The human oocyte cryopreservation market is undergoing revolutionary changes, influenced by enhanced cryopreservation technologies, changing society, and increased regulatory support. Trends like developments in techniques, increased social acceptance, insurance coverage extension, integration of AI, and changing policies are revolutionizing the landscape of fertility preservation. These trends not only enhance the growth of the market but also enhance accessibility, affordability, and the overall success rates of oocyte cryopreservation services.

Recent Developments in the Human Oocyte Cryopreservation Market

Recent trends in the human oocyte cryopreservation market are mainly influenced by innovation, shifting societal norms, and altering regulatory environments. These have led to a rising application of fertility preservation methods across the world. The subsequent section identifies five major trends that are defining the market's contemporary situation.

• Developments in Vitrification Technology: Cryopreservation via vitrification, a technology of the last decade, transformed the human oocyte cryopreservation industry. The technique shields the cells against ice crystal damage during freezing and thus enhances preserved egg quality, as well as success rates when thawed, thereby becoming a widely accepted technology for freezing eggs, leading to the extensive implementation of oocyte cryopreservation. This technology has rendered egg freezing more efficient and reliable, with better results for women who opt to store their fertility.
• Increase in Fertility Preservation Services: Faced with increasing demand, fertility centers are now offering oocyte cryopreservation services more frequently. Centers are now broadening their services to include egg freezing packages for women who wish to delay childbearing as a result of career or personal factors. Besides, fertility preservation services are increasingly becoming affordable and accessible, allowing a wider population to benefit from egg freezing. This growth is fueling market expansion, especially in urban centers where women can access fertility clinics and services.
• Government Policy Support for Fertility Preservation: Governments in various nations are starting to support fertility preservation as part of national policy efforts to address shrinking birth rates. For instance, in Japan and certain European nations, lawmakers are persuading women to freeze their eggs by offering support through financial aid or reduced-cost health care alternatives. The support is aiding the process of normalizing egg freezing as a reproductive health treatment, thus encouraging its expansion and availability. With changes in government policies, the oocyte cryopreservation market is also set for continued growth.
• Greater Emphasis on Egg Freezing for Medical Purposes: Oocyte cryopreservation is now more frequently being done for medical purposes, like helping to preserve fertility for women who are receiving cancer treatment or other medical conditions that can impact the reproductive system. As word gets out about the possibility of medical egg freezing, more women are using cryopreservation to preserve their fertility before receiving treatments that can damage their ability to have children. This healthcare use of egg freezing is widening the market beyond elective fertility preservation, making increased demand for cryopreservation services.
• Integration of Technology with AI for Egg Quality Analysis: The application of AI to evaluate the quality of eggs for freezing is a new trend in the market. AI technology is being incorporated into fertility clinics to evaluate oocyte quality and estimate the probability of success upon fertilization. This integration ensures that cryopreservation becomes more efficient and successful by ensuring that eggs of the highest quality are preserved. AI-powered tools are becoming an integral part of the fertility treatment process, fueling innovation within the oocyte cryopreservation industry.

New developments within the human oocyte cryopreservation market, such as innovation in vitrification technology, increased service options, governmental policy endorsement, growth of medical egg freezing, and AI implementation, are revolutionizing the market. These changes are stimulating market expansion, increasing accessibility, and advancing fertility preservation success rates, eventually giving women more control over their reproductive life and paving the way for general acceptance of oocyte cryopreservation.

Strategic Growth Opportunities in the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market is expected to grow further as fertility preservation gains popularity and access. With increasing demand caused by shifting social norms, technological advances, and improved health care access, a number of strategic growth opportunities are arising. Below are highlights of principal opportunities for growth in the market.

• Growth in Developing Markets: Developing countries across Asia, Africa, and Latin America hold enormous growth opportunities for oocyte cryopreservation services. Due to increased awareness about fertility preservation and enhanced healthcare infrastructure, there is growing demand from women in these markets for fertility services. Clinics and healthcare providers extending into these emerging markets can fill the growing need for egg freezing services, increasing market growth.
• Collaborations with Insurance Companies: With increasing frequency in fertility preservation, collaborations between insurance companies and fertility clinics can facilitate the affordability of oocyte cryopreservation services. By integrating egg freezing in health insurance packages, providers can increase the accessibility of these services to a broader population, especially women aged in their 30s and 40s who might be considering fertility preservation due to medical or personal factors.
• Technological Advancements in Cryopreservation: Techniques Ongoing advancements in cryopreservation technologies, such as ongoing refinement of vitrification, provide expansion opportunities for businesses engaged in oocyte cryopreservation. Through investing in research and development of improved and improved cryopreservation methods, stakeholders are able to further enhance egg survival and thawing success rates, which will increase customer satisfaction and adoption of services.
• Focus on Fertility Preservation for Medical Reasons: As more people become aware of the need to preserve fertility prior to exposure to treatments such as chemotherapy, fertility clinics that provide specialized services to women who are receiving medical treatment have ample opportunity for growth. Offering cheap and accessible egg freezing for medical purposes, such as treating cancer, can allow clinics to reach a new set of patients and grow market demand for cryopreservation services.
• Integration of AI with Egg Quality: The use of AI in the integration of egg freezing services poses great growth possibilities. AI enhances the quality control of eggs frozen, thus heightening success and enhancing patient success. Fertility clinics that apply AI technology for their cryopreservation processes improve their competitive positioning and attract new patients by utilizing sophisticated, accuracy-based fertility therapy.

human oocyte cryopreservation market holds huge growth possibilities in emerging regions, collaborations with insurance companies, development in cryopreservation techniques, medical condition-based fertility preservation, and artificial intelligence integration. All these chances are likely to drive the expansion of the market through enhanced access, increased success rates, and improved patient experiences. By acting on these drivers, market participants can expand their market share as well as propel the development of fertility preservation across the globe.

Human Oocyte Cryopreservation Market Driver and Challenges

The human oocyte cryopreservation market is affected by several drivers and challenges associated with technological innovation, shifting societal perceptions, economic conditions, and regulatory changes. Although these drivers are driving the growth of the market, there are some challenges that need to be overcome for further growth. The subsequent section outlines the major drivers and challenges in the market.

The factors responsible for driving the human oocyte cryopreservation market include:

1. Cryopreservation Technologies: Advances in technologies of cryopreservation, notably vitrification, have led to improved post-thaw success rates of egg cryopreservation. These technologies enable improved quality preservation of the egg, giving rise to enhanced post-thaw success rates. Advances in the technologies of cryopreservation will be instrumental in increasing the size of the market as women feel increasingly assured regarding the dependability of egg freezing.

2. Shift in Social Norms and Postponed Childbearing: As social norms change, increasing numbers of women are postponing childbearing due to career, education, and personal preference. The increased trend of delayed marriages and childbearing, especially in developed countries, has increased the demand for fertility preservation procedures. This shift in social norms is one of the key factors driving the expansion of the oocyte cryopreservation market.

3. Greater Awareness and Accessibility: Rising awareness of fertility preservation alternatives, along with greater access to fertility clinics and treatment, is stimulating oocyte cryopreservation adoption. Greater public awareness through media campaigns, healthcare professionals, and advocacy organizations is urging more women to take egg freezing into consideration as part of their reproductive health choices.

4. Government Assistance and Fertility Policies: There is growing government assistance for fertility preservation services in many countries, and policies and measures are being made to cope with declining birth rates. Subsidized fertility preservation services or funding incentives are offered to women in some places, who are weighing the possibility of egg freezing. These policies have made fertility preservation more widely accessible to more women.

5. Fertility Preservation Demand Due to Medical Procedures: The increasing demand for fertility preservation services for women who are undergoing medical procedures, including chemotherapy, is one of the major drivers of market growth. With more medical practitioners acknowledging the need to preserve fertility in women who are receiving cancer treatment and other medical procedures, more women are freezing their eggs.

Challenges in the human oocyte cryopreservation market are:

1. Excessive Price of Oocyte Cryopreservation: Egg freezing remains very expensive and continues to present a major hindrance, especially to women lacking insurance coverage. The expense, as well as ovarian stimulation, retrieval, and storage charges, keeps many from access. Notwithstanding increased availability and affordability, price continues to keep it in reach for numerous areas.

2. Ethical and Regulatory Issues: Ethical and regulatory issues regarding assisted reproductive technologies, such as oocyte cryopreservation, still affect the market. Various nations have different regulations on the storage and utilization of frozen eggs, which can slow down market growth. Social controversies regarding the ethics of egg freezing and surrounding technologies can also affect public attitudes and regulatory policies.

3. Restricted Success Rates and Possibility of Egg Quality Degradation: Despite improvements in cryopreservation methods, thawed oocyte success rates may be variable, and egg quality will degrade over time. Women freezing eggs at an earlier age typically have higher success rates, potentially restricting the attractiveness of egg freezing for women in later life. These issues need to be addressed to drive improved market growth and patient satisfaction.

The human oocyte cryopreservation market is driven by technological advancements, changing social norms, increased awareness, government support, and medical fertility preservation demand. However, challenges related to cost, ethical concerns, and variable success rates remain significant obstacles. Addressing these challenges will be crucial for unlocking the full potential of the market and expanding accessibility for women worldwide.

List of Human Oocyte Cryopreservation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies human oocyte cryopreservation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the human oocyte cryopreservation companies profiled in this report include-

• Anova Fertility
• CCRM IVF
• Chill
• CREATE Fertility
• Extend Fertility
• HRC Fertility
• IVF Australia
• Kindbody
• London Women's Clinic
• Manchester Fertility

Human Oocyte Cryopreservation Market by Segment

The study includes a forecast for the global human oocyte cryopreservation market by type, application, and region.

Human Oocyte Cryopreservation Market by Type [Value from 2019 to 2031]:

• Slow-cooling Method
• Flash-freezing Process

Human Oocyte Cryopreservation Market by Application [Value from 2019 to 2031]:

• 25-30 Year Old Female
• 30-35 Year Old Female
• 35-40 Year Old Female
• Others

Human Oocyte Cryopreservation Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Human Oocyte Cryopreservation Market

The human oocyte cryopreservation market has witnessed immense growth over the past few years because of improvement in assisted reproductive technologies, increasing awareness of fertility preservation, and changing societal trends. Oocyte cryopreservation, or egg freezing, is increasingly being opted for by women who desire to freeze their fertility for future utilization. Advances in cryopreservation technology, policy guidelines, and ethical issues have driven the market environment of this market. Growth of the market is especially prominent in nations like the United States, China, Germany, India, and Japan, where fertility preservation is picking up pace.

• United States: Oocyte cryopreservation has been quickly adopted in the United States, particularly by women who desire to defer childbearing due to personal or professional reasons. Improvements in cryopreservation procedures, including vitrification, have dramatically increased egg survival and success rates. Fertility centers nationwide are providing egg freezing services, with an emphasis on providing cost-effective options and accessibility to a wider range of demographics. Additionally, regulatory monitoring by the FDA means that safety procedures are upheld, helping to build confidence among consumers. Oocyte cryopreservation is increasingly available via insurance reimbursement in some areas, again fueling the market growth.
• China: China's human oocyte cryopreservation market is expanding, though, albeit with distinctive challenges, given cultural attitudes towards childbearing and fertility, as well as family planning regulations. Although China's one-child policy has been relaxed, cultural expectations regarding family size and childbearing are still prevalent. However, urbanization and changing social structures have created the growing need for fertility preservation. The Chinese government has recently also endorsed egg freezing in some clinics, especially in women with health conditions that jeopardize their ability to conceive. With ongoing technology improvements in assisted reproductive technologies, China's market for oocyte cryopreservation is ready to grow in the future, primarily in major metropolitan areas.
• Germany: Germany's human oocyte cryopreservation market has been growing steadily, driven by growing acceptability for assisted reproductive technologies and shifting social attitudes towards family planning. The nation boasts a highly regulated healthcare system with high standards for fertility preservation. Although oocyte cryopreservation is easily accessible in fertility clinics, ethical and legal considerations hold substantial influence over the market. The German government's stringent laws regarding reproductive technologies, such as restrictions on the number of embryos that can be preserved, have shaped the uptake of oocyte cryopreservation, particularly among women who wish to postpone childbearing for professional or personal purposes.
• India: India's oocyte cryopreservation market is growing at a fast pace, fueled by growing awareness of fertility preservation and expanding fertility clinic coverage in urban India. Indian women, especially those in urban cities, are increasingly turning towards egg freezing thanks to shifting societal norms, delayed marriages, and the need to pursue careers. Improvements in cryopreservation technologies and more developed healthcare facilities are also allowing women to maintain their fertility. While cost still acts as a deterrent for the majority, improved affordability and availability of fertility procedures are making oocyte cryopreservation a feasible choice for women in India.
• Japan: In Japan, oocyte cryopreservation is becoming popular, particularly with women postponing childbirth because of career goals and social pressures. Japan has the lowest fertility rates in the world, and freezing eggs is perceived as a likely solution for females who wish to retain their reproductive choices. There are government policies that have been supporting fertility preservation, and improvement in cryopreservation technology has been enhancing egg freezing success. Yet, social beliefs regarding reproductive technology continue to transform, and market expansion is conditioned by cultural perspectives on children and family, coupled with regulatory complications.

Features of the Global Human Oocyte Cryopreservation Market

Market Size Estimates: Human oocyte cryopreservation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Human oocyte cryopreservation market size by type, application, and region in terms of value ($B).

Regional Analysis: Human oocyte cryopreservation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the human oocyte cryopreservation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the human oocyte cryopreservation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the human oocyte cryopreservation market by type (slow-cooling method and flash-freezing process), application (25-30 year old female, 30-35 year old female, 35-40 year old female, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Human Oocyte Cryopreservation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Human Oocyte Cryopreservation Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Human Oocyte Cryopreservation Market by Type
  • 3.3.1: Slow-cooling Method
  • 3.3.2: Flash-freezing Process
• 3.4: Global Human Oocyte Cryopreservation Market by Application
  • 3.4.1: 25-30 Year Old Female
  • 3.4.2: 30-35 Year Old Female
  • 3.4.3: 35-40 Year Old Female
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Human Oocyte Cryopreservation Market by Region
• 4.2: North American Human Oocyte Cryopreservation Market
  • 4.2.1: North American Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.2.2: North American Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.3: European Human Oocyte Cryopreservation Market
  • 4.3.1: European Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.3.2: European Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.4: APAC Human Oocyte Cryopreservation Market
  • 4.4.1: APAC Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.4.2: APAC Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others
• 4.5: ROW Human Oocyte Cryopreservation Market
  • 4.5.1: ROW Market by Type: Slow-cooling Method and Flash-freezing Process
  • 4.5.2: ROW Market by Application: 25-30 Year Old Female, 30-35 Year Old Female, 35-40 Year Old Female, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Type
  • 6.1.2: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Application
  • 6.1.3: Growth Opportunities for the Global Human Oocyte Cryopreservation Market by Region
• 6.2: Emerging Trends in the Global Human Oocyte Cryopreservation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Human Oocyte Cryopreservation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Oocyte Cryopreservation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Anova Fertility
• 7.2: CCRM IVF
• 7.3: Chill
• 7.4: CREATE Fertility
• 7.5: Extend Fertility
• 7.6: HRC Fertility
• 7.7: IVF Australia
• 7.8: Kindbody
• 7.9: London Women's Clinic
• 7.10: Manchester Fertility